Trials / Unknown
UnknownNCT06290375
A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.
A Multi-center Stage II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of HSK21542 Tablets for the Treatment of Moderate-to-severe Pruritus in Peritoneal Dialysis Subjects
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Xizang Haisco Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a two- stage study. Stage I is a multicenter, open-label trial；Stage II was a multi-center, randomized, double-blind, placebo-controlled trial. About 250 maintenance peritoneal dialysis patients with moderate or above pruritus are planned to be enrolled.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HSK21542 tablet | once-daily |
| DRUG | Placebo | once-daily |
Timeline
- Start date
- 2024-03-08
- Primary completion
- 2024-03-08
- Completion
- 2025-04-11
- First posted
- 2024-03-04
- Last updated
- 2024-03-04
Source: ClinicalTrials.gov record NCT06290375. Inclusion in this directory is not an endorsement.